These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7961219)

  • 1. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD; Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV; Tubert TA; Chapin K; Rinaldi MG
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
    Fromtling RA; Abruzzo GK; Bulmer GS
    Mycopathologia; 1986 Apr; 94(1):27-30. PubMed ID: 3014339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Swinne D; Raes-Wuytack C; Van Looveren K; Desmet P
    Mycoses; 1999; 42(4):231-7. PubMed ID: 10424089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
    Poon M; Cronin DC; Wormser GP; Bottone EJ
    Arch Pathol Lab Med; 1988 Feb; 112(2):161-2. PubMed ID: 3276290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
    Del Poeta M; Barchiesi F; Morbiducci V; Arzeni D; Marinucci G; Ancarani F; Scalise G
    J Chemother; 1994 Jun; 6(3):173-6. PubMed ID: 7983499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Mary C; Goudard M; Blancard A; Quilici M; Regli P
    Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs].
    Bava AJ; Negroni R
    Rev Inst Med Trop Sao Paulo; 1989; 31(5):346-50. PubMed ID: 2560840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Still JM; Law EJ; Belcher KE; Spencer SA
    Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of clinical isolates of yeasts to anti-fungal agents.
    Hussain Qadri SM; Flournoy DJ; Qadri SG; Ramirez EG
    Mycopathologia; 1986 Sep; 95(3):183-7. PubMed ID: 3773980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
    Lombardi G; Gramegna G; Cavanna C; Poma G; Marangoni E; Michelone G
    Mycopathologia; 1989 Apr; 106(1):31-4. PubMed ID: 2549421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.